Nahzli Dilek joined the SIB in June 2014 as postdoctoral fellow researcher. After a Master Degree in Pharmacology, she has obtained her PhD in Immunology in 2011 at University of Nantes in France. She worked on the evaluation of innovative therapeutic strategies in transplantation and on new therapeutic approaches to modulate the human immune system. She then went on to a post-doctoral fellow at Ludwig Institute for Cancer Research in Lausanne before joining the group of Dr. Olivier Michielin. She is currently working on the optimization and characterization of cancer immunotherapy.